133 filings
Page 4 of 7
6-K
OPT
Opthea Limited
11 May 22
Opthea To Present at Upcoming Investor Conferences
6:03am
6-K
OPT
Opthea Limited
10 May 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
5 May 22
Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022
6:02am
6-K
OPT
Opthea Limited
29 Apr 22
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
6:03am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
7:01am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
7:00am
6-K
OPT
Opthea Limited
22 Apr 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
30 Mar 22
Index to Condensed Consolidated Financial Statements
5:18pm
6-K
OPT
Opthea Limited
10 Mar 22
Opthea To Present at Oppenheimer’s 32nd Annual Healthcare Conference
4:15pm
6-K
OPT
Opthea Limited
2 Mar 22
Current report (foreign)
4:16pm
6-K
OPT
Opthea Limited
28 Feb 22
Current report (foreign)
6:10am
EFFECT
OPT
Opthea Limited
28 Feb 22
Notice of effectiveness
12:15am
CORRESP
OPT
Opthea Limited
23 Feb 22
Correspondence with SEC
12:00am
SC 13G/A
OPT
Opthea Limited
14 Feb 22
Opthea / REGAL FUNDS MANAGEMENT PTY ownership change
4:21pm
6-K
OPT
Opthea Limited
14 Feb 22
Current report (foreign)
6:41am
SC 13G/A
Baker Bros. Advisors LP
14 Feb 22
Opthea / BAKER BROS. ADVISORS ownership change
12:00am
6-K
OPT
Opthea Limited
10 Feb 22
Opthea To Present at SVB Leerink Global Healthcare Conference
4:01pm
6-K
OPT
Opthea Limited
9 Feb 22
Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference
5:16pm
UPLOAD
OPT
Opthea Limited
7 Feb 22
Letter from SEC
12:00am
6-K
OPT
Opthea Limited
1 Feb 22
Opthea Announces Establishment of At-The-Market Equity Program
6:46am